| 000 | 01408 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513043358.0 | ||
| 264 | 0 | _c19950718 | |
| 008 | 199507s 0 0 eng d | ||
| 022 | _a0300-8126 | ||
| 024 | 7 |
_a10.1007/BF02464955 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScott, W G | |
| 245 | 0 | 0 |
_aPharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study. _h[electronic resource] |
| 260 |
_bInfection _c1995 |
||
| 300 |
_aS21-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmoxicillin _xeconomics |
| 650 | 0 | 4 | _aAmoxicillin-Potassium Clavulanate Combination |
| 650 | 0 | 4 |
_aClavulanic Acids _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRespiratory Tract Infections _xdrug therapy |
| 650 | 0 | 4 |
_aRoxithromycin _xeconomics |
| 700 | 1 | _aCooper, B C | |
| 700 | 1 | _aScott, H M | |
| 773 | 0 |
_tInfection _gvol. 23 Suppl 1 _gp. S21-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02464955 _zAvailable from publisher's website |
| 999 |
_c7781476 _d7781476 |
||